Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease
University of British Columbia
$45,000.00
Epigenetic regulation of CD4+ T cell dependent immunity and inflammation
EF 2010-11
Résumé
The human body fights off infections using several types of white blood cells, such as helper T cells (Th), to kill invading germs. Once Th cells encounter an infectious microbe, they can develop into one of several types of activated cells including Th1, Th2 or Th17 cells. This choice is absolutely critical as each type of cell has a different function in the body. Th1 cells kill bacteria and viruses, Th2 cells attack worm parasites and Th17 cells control fungal infections. However, uncontrolled or inappropriate Th cell responses can also cause autoimmune disease like arthritis, Multiple Sclerosis, asthma and allergies. Thus, appropriate control of helper T cell development is critical for preventing infection and autoimmune disease.
The gut is a unique environment that must simultaneously tolerate an endless variety of foods and billions of helpful bacteria, while retaining the ability to recognize and respond to dangerous infectious diseases. In Canada, over 200,000 people suffer from inflammatory bowel disease (one of the world's highest incidence rates) and each year over 20,000 Canadians will be diagnosed with colorectal cancer, a disease linked to inflammation. The focus of this proposal is to understand how helper T cell development choices are made in the gut. We have identified two molecules, G9a and Set7, which play important roles in this decision process. In the absence of G9a, Th cells cannot become Th2 cells. This is a good thing for preventing asthma and ulcerative colitis but a bad thing if you are infected with an intestinal worm parasite. On the other hand in the absence of Set7, Th cells preferentially become Th2. Although this could prevent chronic infection with a worm parasite, it may make asthma worse. How G9a and Set7 control this choice is completely unknown. Our research will answer this important question and may identify new drug targets that could aid in the treatment of infections and autoimmune disease.
Programme
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
215890
Name
Antignano Frann
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Epigenetic regulation of CD4+ T cell dependent immunity and inflammation
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
Conditional Deletion Mouse Model; Cytokine Biology; Epigenetics; Helminth Immunity; Helper T Cells; Immunoparasitology; Inflammatory Bowel Disease; Lysine-Methyltransferase (G9a And Set7); Mucosal Immunity
Abstract
The human body fights off infections using several types of white blood cells, such as helper T cells (Th), to kill invading germs. Once Th cells encounter an infectious microbe, they can develop into one of several types of activated cells including Th1, Th2 or Th17 cells. This choice is absolutely critical as each type of cell has a different function in the body. Th1 cells kill bacteria and viruses, Th2 cells attack worm parasites and Th17 cells control fungal infections. However, uncontrolled or inappropriate Th cell responses can also cause autoimmune disease like arthritis, Multiple Sclerosis, asthma and allergies. Thus, appropriate control of helper T cell development is critical for preventing infection and autoimmune disease.
The gut is a unique environment that must simultaneously tolerate an endless variety of foods and billions of helpful bacteria, while retaining the ability to recognize and respond to dangerous infectious diseases. In Canada, over 200,000 people suffer from inflammatory bowel disease (one of the world's highest incidence rates) and each year over 20,000 Canadians will be diagnosed with colorectal cancer, a disease linked to inflammation. The focus of this proposal is to understand how helper T cell development choices are made in the gut. We have identified two molecules, G9a and Set7, which play important roles in this decision process. In the absence of G9a, Th cells cannot become Th2 cells. This is a good thing for preventing asthma and ulcerative colitis but a bad thing if you are infected with an intestinal worm parasite. On the other hand in the absence of Set7, Th cells preferentially become Th2. Although this could prevent chronic infection with a worm parasite, it may make asthma worse. How G9a and Set7 control this choice is completely unknown. Our research will answer this important question and may identify new drug targets that could aid in the treatment of infections and autoimmune disease.
Competitiondate
201010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Antignano, Frann
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $45,000~ $0~